Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 2,463

We as human have to live with a lot of unfortunate realities, including the fact that a lot of the things we love end up being bad for us. We all know by now that if we binge on tasty treats too much we’ll end up eating ourselves into an early grave, but in recent years it’s become increasingly clear that coffee, a well known vice of millions and millions of people, is actually pretty good for you.

Recent studies have shown that being a regular coffee drinker can reduce your risk of all kinds of ailments, including heart attack and stroke. Now, a new research effort reveals that dark roast coffee is particularly good at warding off some nasty brain conditions, including Alzheimer’s and Parkinson’s disease.

Read more

Free drug cocktails for everyone, yay! 😏.

Sixty-nine pharmaceutical compounds have been detected in stream insects, some at concentrations that may threaten animals that feed on them, such as trout and platypus. When these insects emerge as flying adults, they can pass drugs to spiders, birds, bats, and other streamside foragers. These findings by an international team of researchers were published today in Nature Communications.

Read more

Scientists in Japan have developed the world’s first test that can detect cancers in patient urine samples. The breakthrough technology by Japanese researchers from engineering firm Hitachi has been in development for two years and it may be made available by 2020.

According to Agence France-Presse, the research team will work with Nagoya University to analyze 250 urine samples to check for breast, colon, and childhood forms of the disease in central Japan. The experiments will begin this month and end in September.

Read more

Through a new approach dubbed AMBAR, the biotechnology company Grifols has attempted to reduce the amount of harmful, Alzheimer’s disease-causing amyloid beta in the brain by collecting it with a blood protein called albumin and draining it out of the bloodstream. This approach differs from the previous antibody and catabody approaches and offers new hope for sufferers of this neurodegenerative disease.

What is Alzheimer’s disease?

Alzheimer’s disease, named after its discoverer, is a slow and progressive disease that causes the degradation of the brains of its sufferers. This leads to memory loss, a decrease in problem-solving abilities, changes in personality, and other symptoms. It is associated with the accumulation of tau and amyloid beta in the brain.

Read more